The pathophysiology of diabetic complications: How much does the glucose hypothesis explain?

Annals of Internal Medicine

Volumn 124, Issue 1 II, 1996, Pages 86-89

  Nathan, David M ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; CONFERENCE PAPER; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; GLUCOSE INTOLERANCE; HUMAN; HYPERGLYCEMIA; MICROVASCULATURE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0030048983     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-124-1_part_2-199601011-00002     Document Type: Conference Paper

References (51)

1. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance Diabetes 1979;28 1039-57
2. Pirart J. Diabetes mellitus and its degenerative complications a prospective study of 4,400 patients observed between 1947 and 1973 Diabetes Care 1978, 1 168-88, 252-61
3. Knowles HC. The problem of the relation of the control of diabetes to the development of vascular disease Trans Am Clin Climatol Assoc 1964, 76 142-7
4. Nathan DM, Singer DE, Hurxthal K, Goodson JD. The clinical information value of the glycosylated hemoglobin assay N Engl J Med. 1984, 310 341-6
5. Klein R, Klein BE, Moss SE, David MD, Demets DL. The Wisconsin epidemiologic study of diabetic retinopathy III Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984, 102 527-32
6. Nathan DM, Singer DE, Godine JE, Harrington CH, Perlmuter LC. Retinopathy in older type II diabetics Association with glucose control Diabetes 1986,35 797-801
7. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy JAMA 1988;260 2864-71
8. Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D. Glucose control and the renal and retinal complications of insulin-dependent diabetes JAMA 1989,261 1155-60
9. Joint discussion the International Collaborative Group. J Chronic Dis 1979, 32 829-37
10. Singer DE, Nathan DM, Anderson KM, Wilson PW, Evans JC. Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study Diabetes 1992;41 202-8
11. Engerman R, Bloodworth JM Jr, Nelson S. Relationship of microvascular disease in diabetes to metabolic control. Diabetes 1977,26 760-9
12. Cohen AJ, McGill PD, Rossetti RG, Guberski DL, Like AA. Glomerulopathy in spontaneously diabetic rat. Impact of glycemic control. Diabetes 1987; 36 944-51.
13. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus N Engl J Med 1993,329.304-9.
14. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
15. Gabbay KH, Merola LO, Field RA. Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science. 1966, 151.209-10
16. Betz AL, Bowman PD, Goldstein GW. Hexose transport in microvascular endothelial cells cultured from bovine retina Exp Eye Res 1983;36:269-77.
17. Corder CN, Braughler JM, Culp PA. Quantitative histochemistry of the sorbitol pathway in glomeruli and small arteries of human diabetic kidney. Folia Histochem Cytochem (Krakow) 1979,17.137-45.
18. Bloodworth JM. Diabetic retinopathy Diabetes 1962;11 1-22
19. Osterby R. Early phases in the development of diabetic glomerulopathy Acta Med Scand Suppl 1985,574 3-82
20. Steffes MW, Osterby R, Chavers B, Mauer SM. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients Diabetes. 1989,38.1077-81
21. Greene DA, Lattimer SA, Sima AA. Sorbitol, phosphomositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 1987;316.599-606
22. Asbury AK, Aldredge H, Hershberg R, Fisher CM. Oculomotor palsy in diabetes mellitus a clinico-pathological study Brain 1970,93 555-56
23. Raff MC, Sangalang V, Asbury AK. Ischemic mononeuropathy multiplex associated with diabetes mellitus Arch Neurol 1968;18:487-99.
24. Andersen AR, Christianen JS, Andersen JK, Kreiner S, Deckert T. Dia-betic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983,25:496-501
25. Ballard DJ, Humphrey LL, Melton LJ 3d, Frohnert PP, Chu PC, O'Fallon WM, et al. Epidemiology of persistent proteinuna in type II diabetes mellitus. Population-based study in Rochester, Minnesota. Diabetes 1988,37 405-12
26. Parving HH, Smidt UM, Friisberg B, Bonnevie-Nielsen V, Andersen AR. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy Diabetologia 1981;20:457-61
27. Hostetter TH, Rennke HG, Brenner BM. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies Am J Med. 1982,72:375-80
28. Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy in diabetics with elevated blood pressure A six-year follow-up study in Pima Indians. N Engl J Med 1980,302.645-50.
29. Patz A. Studies on retinal neovascularization Friedenwald Lecture Invest Ophthalmol Vis Sci 1980,19:1133-8
30. Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med. 1994;331.1480-7
31. Frank RN. The aldose reductase controversy. Diabetes. 1994,43.169-72
32. Brownlee M. Glycation products and the pathogenesis of diabetic complications Diabetes Care 1992;15 1835-43.
33. Gabbay KH. The sorbitol pathway and the complications of diabetes N Engl J Med. 1973,288 831-6
34. +-ATPase regulation involved in pathogenesis of diabetic neuropathy? Diabetes 1988,37 688-93.
35. Beyer-Mears A, Cruz E. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor. Diabetes 1985,34:15-21
36. Engerman RL, Kern TS, Larson ME. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs Diabetologia. 1994;37 141-4
37. Sima AA, Prashar A, Nathaniel V, Bril V, Werb MR, Greene DA. Overt diabetic neuropathy repair of axo-glial dysjunction and axonal atrophy by aldose reductase inhibition and its correlation to improvement in nerve conduction velocity Diabet Med. 1993,10 115-21
38. Fagius J, Brattberg A, Jameson S, Berne C. Limited benefit of treatment of diabetic polyneuropathy with an aldose reductase inhibitor a 24-week controlled trial Diabetologia 1985,28 323-9.
39. Krentz AJ, Honigsberger L, Ellis SH, Hardman M, Nattrass M. A 12-month randomized controlled study of the aldose reductase inhibitor ponalrestat in patients with chronic symptomatic diabetic neuropathy Diabet Med 1992,9 463-8
40. Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus Biochem Biophys Res Commun 1969,36 838-43
41. Bunn HF, Haney DN, Gabbay KH, Gallop PM. Further identification of the nature and linkage of the carbohydrate in hemoglobin A1c Biochem Biophys Res Commun 1975,67.103-9
42. Kapoor A, Sibbitt WL Jr. Contractures in diabetes mellitus the syndrome of limited joint mobility Semin Arthritis Rheum 1989; 18 168-80.
43. Cerami A, Vlassara H, Brownlee M. Role of advanced glycosylation products in complications of diabetes Diabetes Care 1988,11(Suppl 1):73-9
44. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy Proc Natl Acad Sci USA 1991,88 11555-8
45. Zatz R, Brenner BM. Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 1986,80 443-53
46. Tesfaye S, Malik R, Ward JD. Vascular factors in diabetic neuropathy Diabetologia 1994,37.847-54
47. Hill MA, Meininger GA. Impaired arteriolar myogenic reactivity in early experimental diabetes. Diabetes. 1993;42 1226-32
48. Craven PA, Caines MA, DeRubertis FR. Sequential alterations in in glomerular prostaglandin and thromboxane synthesis in diabetic rats relationship to the hyperfiltration in early diabetes Metabolism 1987,36:95-103
49. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, et al. Hyperglycemic pseudohypoxia and diabetic complications Diabetes 1993,42 801-13
50. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest. 1992,90:2548-54
51. Smits P, Kapma JA, Jacobs MC, Lutterman J, Thien T. Endothelium-dependent vascular relaxation in patients with type I diabetes Diabetes 1993,42 148-53.